Loading the company…
Loading the company…
Families: Bone graft & orthobiologics, Lumbar fusion, Bariatric surgery, Antireflux & hiatal hernia surgery, Colorectal resection, Cholecystectomy & appendectomy, Skin substitutes & wound grafts.
All companies · Product and company coverage
In 2025, Anika Therapeutics reported engagement with 352 surgeons and other clinicians in the states MedaRep covers, worth $320K in consulting, speaking, meals and travel for its device products, the most in Massachusetts ($84K to 14). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Massachusetts ($84K, 14 engaged), Florida ($73K, 49 engaged), Colorado ($29K, 4 engaged), Maryland ($28K, 4 engaged), New Jersey ($23K, 4 engaged).
In the last ten years FDA made 8 decisions for Anika Therapeutics (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 6 procedure families, the most in 2023 (4). The latest was on 2026-09-17.
| Tactoset |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Anika Therapeutics.